ArticleCancers2022

An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1.

Daniel Doheny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.